A direct comparison of two nonviral gene therapy vectors for somatic integration: in vivo evaluation of the bacteriophage integrase ϕC31 and the Sleeping Beauty transposase
Open Access
- 1 May 2005
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 11 (5) , 695-706
- https://doi.org/10.1016/j.ymthe.2005.01.010
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Episomal Persistence of Recombinant Adenoviral Vector Genomes during the Cell Cycle In VivoJournal of Virology, 2003
- Sustainable correction of junctional epidermolysis bullosa via transposon-mediated nonviral gene transferGene Therapy, 2003
- Site-specific genomic integration produces therapeutic Factor IX levels in miceNature Biotechnology, 2002
- HIV-1 Integration in the Human Genome Favors Active Genes and Local HotspotsCell, 2002
- CpG-Depleted Plasmid DNA Vectors with Enhanced Safety and Long-Term Gene Expression in VivoMolecular Therapy, 2002
- Chromosomal effects of adeno-associated virus vector integrationNature Genetics, 2002
- Linear DNAs Concatemerize in Vivo and Result in Sustained Transgene Expression in Mouse LiverMolecular Therapy, 2001
- Inclusion of the Hepatic Locus Control Region, an Intron, and Untranslated Region Increases and Stabilizes Hepatic Factor IX Gene Expression in Vivo but Not in VitroMolecular Therapy, 2000
- A Simple Method for Constructing E1- and E1/E4-Deleted Recombinant Adenoviral VectorsHuman Gene Therapy, 1999
- Efficient Construction of a Recombinant Adenovirus Vector by an ImprovedIn VitroLigation MethodHuman Gene Therapy, 1998